About
Technology
Issues
FAQ
Links
Official Page
696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.